2023. Perspectives for the Use of Bispecific Antibodies in the Third- and Subsequent-Line Therapies of Follicular Lymphoma (Resolution of Expert Panel). Clinical Oncohematology. Basic Research and Clinical Practice. 16, 2 (Mar. 2023), 227–228. DOI:https://doi.org/10.21320/6nkr3a68.